BamSEC and AlphaSense Join Forces
Learn More

Immunome Inc.

NASDAQ: IMNM    
Share price (1/8/25): $10.66    
Market cap (1/8/25): $665 million

Material Contracts Filter

EX-10.2
from 10-Q 4 pages Background
12/34/56
EX-10.1
from 10-Q 11 pages May 24, 2024 Phil Tsai Re:immunome, Inc. Employment Offer Dear Phil
12/34/56
EX-10.38
from 10-K 6 pages ​ April 26, 2021 ​ Robert Lapetina 708 Julian Drive Collegeville, Pa 19426 ​ Dear Bob, ​ on Behalf of Immunome, Inc. (The “Company”), I Am Pleased to Make This Conditional Offer of Employment to You as Our Controller. the Purpose of This Letter Agreement Is to Set Forth the Terms of the Offer and Your Employment Should You Accept the Offer. ​ 1. Position: Duties: ​
12/34/56
EX-10.37
from 10-K 65 pages Asset Purchase Agreement ​ by and Between ​ Atreca, Inc. ​ and ​ Immunome, Inc. ​ Dated as of December 22, 2023 ​
12/34/56
EX-10.34
from 10-K 10 pages October 3, 2023 by Hand and Email Purnanand Sarma Sarmap97@gmail.com Re:separation Agreement Dear Sarma
12/34/56
EX-10.33
from 10-K 9 pages Immunome, Inc. Consulting Agreement
12/34/56
EX-10.32
from 10-K 9 pages October 2, 2023 by Hand and Email Dennis Giesing Dhgiesing@gmail.com Re:separation Agreement Dear Dennis
12/34/56
EX-10.30
from 10-K 56 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Zentalis Pharmaceuticals, Inc. and Immunome, Inc. License Agreement January 5, 2024 ​
12/34/56
EX-10.23
from 10-K 11 pages February 7, 2024 Kinney Horn Re:immunome, Inc. Employment Offer Dear Kinney
12/34/56
EX-10.22
from 10-K 11 pages November 30, 2023 Philip Roberts Re:immunome, Inc. Employment Offer Dear Phil
12/34/56
EX-10.21
from 10-K 11 pages ​ November 30, 2023 Robert Lechleider, M.D. ​ Re:immunome, Inc. Amended and Restated Employment Offer Terms Dear Bob
12/34/56
EX-10.20
from 10-K 12 pages ​ November 30, 2023 Jack Higgins ​ Re:immunome, Inc. Amended and Restated Employment Offer Terms Dear Jack
12/34/56
EX-10.19
from 10-K 11 pages ​ November 30, 2023 Max Rosett Re:immunome, Inc. Amended and Restated Employment Offer Terms Dear Max
12/34/56
EX-10.18
from 10-K 11 pages December 14, 2023 Bruce Turner Re:immunome, Inc. Amended and Restated Employment Offer Terms Dear Bruce
12/34/56
EX-10.17
from 10-K 11 pages November 30, 2023 Sandra Stoneman Re:immunome, Inc. Amended and Restated Employment Offer Terms Dear Sandra
12/34/56
EX-10.16
from 10-K 2 pages Amendment No. 1 to Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 68 pages License Agreement
12/34/56
EX-10.1
from 8-K 12 pages Support Agreement
12/34/56
EX-10.2
from 8-K 11 pages Immunome, Inc. Consulting Agreement
12/34/56
EX-10.1
from 8-K 9 pages December 21, 2023 by Email Corleen Roche Re: Separation Agreement Dear Corleen
12/34/56